RecruitingOBSERVATIONAL

SafeTy and Outcome of contemPorary Treatment Strategies for Cardiogenic SHOCK

This study is an international registry, which means it collects information about many patients with a serious heart condition called cardiogenic shock. Researchers want to understand the different ways doctors are currently treating this condition across various hospitals. They are particularly interested in seeing how well certain treatments work, such as special procedures, machines that help the heart, and new heart medications. By gathering this information, the study aims to find out which treatment strategies lead to the best results for patients. This is not a study where new medicines or treatments are tested; instead, it observes and records what is already happening in real-world hospital settings to improve future care.

At a glance

Status

Recruiting

Sponsor

Universitätsklinikum Hamburg-Eppendorf

Enrolment target

2,500

Start

01 Sep 2017

Estimated completion

31 Dec 2031

Cardiogenic Shock

What is this study about?

This study is about a very serious heart condition called cardiogenic shock. This happens when your heart suddenly can't pump enough blood to meet your body's needs. When this occurs, it's a medical emergency that requires immediate treatment in a hospital. Doctors use many different methods to help patients with cardiogenic shock, including various medications, special devices that support the heart, and procedures.

This study is like a large, organised notebook where doctors and researchers are writing down what they see happening in hospitals around the world. They are carefully observing how patients with cardiogenic shock are currently being treated. They want to know which treatments are being used, how well they work, and if there are any side effects. They're particularly focusing on modern treatment methods to see how they affect patients' health and recovery.

The main goal of this study is to understand more clearly which treatment approaches are most effective for people with cardiogenic shock. By collecting detailed information from many hospitals, researchers hope to gain a better picture of current practices and identify the best ways to help patients recover. This knowledge can then be used to improve the care that patients receive in the future.

Key takeaways

It's about a serious heart condition called cardiogenic shock.
The study watches how patients are currently treated, not testing new treatments.
It aims to find out which treatments work best for patients.
Only adults (18+) being treated for cardiogenic shock can take part.
Taking part involves sharing information about your existing hospital care.

Who may be eligible?

To take part in this study, you must be an adult (18 years old or older) who is currently being treated for cardiogenic shock in a specialist hospital that is part of this study.

This means that the study is only for those who are already receiving care for this specific heart condition in a hospital setting where the study is being conducted. It's not for people who are under 18 years old.

Essentially, if you are an adult patient being looked after for cardiogenic shock in one of the hospitals involved, you might be able to participate.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

Are you 18 years old or older?
Are you currently being treated for cardiogenic shock?
Is your treatment happening at a specialist hospital?
Has your doctor told you this hospital is involved in this study?

Answer every question to see your result.

What does participation involve?

If you take part in this study, you won't need to do anything extra. This is an 'observational' study, which means doctors will simply collect information about your existing hospital care. They will note down the treatments you receive, such as any medicines you're given or any devices used to help your heart, as part of your standard medical care for cardiogenic shock. They will also keep track of your health and recovery while you are in the hospital. You won't be asked to take any new, experimental drugs or undergo any special procedures just for the study. All the information will be gathered from your routine hospital records during your stay.

Potential risks and benefits

Because this study is observational, meaning it just records what doctors are already doing, there are no direct new risks to you from taking part. You will continue to receive the standard medical care your doctors recommend for your condition. The potential benefit is that the information gathered from your treatment, alongside many other patients, will help doctors understand more about cardiogenic shock and improve treatments for future patients. You are always free to decide not to take part or to withdraw from the study at any time without it affecting your medical care.

Locations (1)

University Heart Center
Verified postcode
Hamburg, Germany· Recruiting

Common questions

What is cardiogenic shock?

Cardiogenic shock is a very serious condition where your heart suddenly can't pump enough blood to meet your body's needs. It's a medical emergency.

Will I receive new treatment if I join this study?

No, this study only observes current treatments. You will continue to receive the standard medical care your doctors recommend for your condition.

Who can take part in this study?

Adults (18 and over) who are being treated for cardiogenic shock in a hospital that is participating in the study.

Will my personal details be shared?

The study will collect information in a way that protects your privacy. Your personal details will not be openly shared.

What is the study hoping to achieve?

The study aims to understand which treatments for cardiogenic shock work best, to improve care for patients in the future.

How to find out more

Benedikt Schrage, MD

b.schrage@uke.de +49 40 7410 18135 Official trial record

Always speak to your GP or specialist before deciding to take part in a study.